Mirae Asset Global Investments Co. Ltd. has a $4.72 million equity position in Myriad Genetics, Inc. (NASDAQ:MYGN)
Mirae Asset Global Investments Co. Ltd. cut its holdings in Myriad Genetics, Inc. (NASDAQ: MYGN – Get Rating) stock by 18.6% in the fourth quarter, according to the company in its most recent disclosure to the Securities and Exchange Commission (SEC). The institutional investor owned 325,422 shares of the company after selling 74,151 shares during…